1月8日 - ** Revolution Medicines RVMD.O股价在盘后交易中上涨 16%，报 125 美元
** 默克MRK.N股价微跌0.6%，报110.30美元
** 同行癌症疗法开发商 Erasca ERAS.O 股价上涨 10.2%，报 6.40 美元
** 英国《金融时报》周四援引知情人士的话报道称，默克公司正在洽谈收购 (link) 癌症药物开发商 Revolution Medicines。
** MRK和RVMD没有立即回应路透的置评请求。
** 截至本周四收盘，MRK上涨2.2%，RVMD上涨4.6%，ERAS上涨56.2%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.